Uroplakin-III to distinguish primary vulvar Paget disease from Paget disease secondary to urothelial carcinoma

Human Pathology

Volumn 33, Issue 5, 2002, Pages 545-548

  Brown, Heather M ^a   Wilkinson, Edward J ^a  

^a UNIVERSITY OF FLORIDA COLLEGE OF MEDICINE   (United States)

Author keywords

Immunohistochemistry; Paget disease; Uroplakin III; Vulva

Indexed keywords

CARCINOEMBRYONIC ANTIGEN; CYTOKERATIN 20; CYTOKERATIN 7; UNCLASSIFIED DRUG; UROPLAKIN; UROPLAKIN III;

ADENOCARCINOMA; AGED; ANUS CARCINOMA; ARTICLE; BLADDER CARCINOMA; CANCER DIAGNOSIS; CANCER INVASION; CLINICAL ARTICLE; ECZEMA; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; PAGET SKIN DISEASE; RECTUM CARCINOMA; URETHRA CARCINOMA; UROTHELIUM; VULVA DISEASE;

EID: 0036305276     PISSN: 00468177     EISSN: None     Source Type: Journal    
DOI: 10.1053/hupa.2002.124787     Document Type: Article

References (10)

1. Vulvar pagetoid urothelial neoplasia: Differentiation from Paget disease of cutaneous or ano-rectal origin
2. Perianal Paget's disease: A histologic and immunohistochemical study of 11 cases with and without associated rectal adenocarcinoma
3. Prognostic factors in paget's disease of the vulva: A study of 21 cases
4. Perianal Paget's disease: Distinguishing primary and secondary lesions using immunohistochemical studies including gross cystic disease fluid protein-15 and cytokeratin 20 expression
5. Extramammary Paget's disease: An annotated review
6. Vulvar Paget's disease: A clinicopathologic and immunohistochemical study of 19 cases
7. Immunohistochemical features of Paget's disease of the vulva with and without adenocarcinoma
8. Cytokeratin 7 staining in mammary and extramammary Paget's disease
9. The use of cytokeratins 7 and 20 in the diagnosis of primary and secondary extramammary Paget's disease
10. Uroplakin III is a highly specific and moderately sensitive immunohistochemical marker for primary and metastatic urothelial carcinomas